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Swimming is practiced extensively in Western 
countries (Vaz et al. 1999). Despite the ben-
efits of physical activity, health concerns are 
growing because swimming in pools involves 
exposure to disinfectants and disinfection by-
products (DBPs), such as trihalomethanes 
(THMs), one of the classes of DBPs at high-
est concentration in swimming pools, and 
trichloramine, a known irritant (World 
Health Organization 2006). A range of acute 
symptoms has been described among bath-
ers after accidental exposure to high levels 
of chlorine in swimming pools, including 
mucosal and ocular irritation, cough, rash, 
dyspnea, and lung function decline (Bonetto 
et al. 2006; Grasemann et al. 2007). Subjects 
exposed chronically to the swimming pool 
environment, such as pool workers, showed 
irritant eye, nasal, and throat symptoms 
(Jacobs et al. 2007; Massin et al. 1998). Cases 
of occupational asthma and trichloramine 
sensitization have been described in pool life-
guards (Thickett et al. 2002). Although an 
increased asthma risk among children attend-
ing pools has been suggested but not con-
firmed (Font-Ribera et al. 2009; Goodman 
and Hays 2008), respiratory symptoms 
and asthma are consistently more prevalent 
among competitive swimmers compared with 
other athletes (Goodman and Hays 2008). 
However, one of the unsolved questions is 
what are the biological mechanisms behind 
these health effects (Bonetto et al. 2006; 
Grasemann et al. 2007).
The development of methods to evalu-
ate respiratory and systemic biomarkers in 
blood, exhaled breath condensate (EBC), and 
exhaled breath has allowed the assessment of 
pathobiological mechanisms underlying respi-
ratory disorders (Bonetto et al. 2006) and the 
detection of early subclinical respiratory effects 
after acute or chronic environmental expo-
sures, including swimming pool attendance. 
Lung surfactant proteins, such as Clara cell 
secretory protein (CC16) or surfactant protein 
D (SP-D), are secreted in the lung epithelium 
and move passively across the epithelial bar-
rier into the serum down a strong gradient 
(Broeckaert et al. 2000). A change in the con-
centration of lung surfactant proteins in serum 
has been proposed as a marker to detect early 
permeability changes in the lung epithelium 
(Broeckaert et al. 2000). Fractional concentra-
tions of orally exhaled nitric oxide (FeNO) 
is a marker of eosinophilic airway inflamma-
tion (Choi et al. 2006) and has been shown 
to increase after short-term exposure to mold 
(Stark et al. 2005). Soluble molecules can be 
detected in EBC, including proinflammatory 
cytokines, growth factors, and oxidative stress 
biomarkers, and have been used to monitor 
different aspects of diseases such as asthma 
or chronic obstructive pulmonary disease, as 
well as the effects of environmental stressors 
or physical exercise (Bonsignore et al. 2003; 
Carbonnelle et al. 2002, 2008; Massin et al. 
1998; Nanson et al. 2001).
Proposed mechanisms of respiratory 
damage related to swimming pool exposure 
include airway inflammation (Bonetto et al. 
2006; Grasemann et al. 2007; Moreira et al. 
2008; Pedersen et al. 2009), oxidative stress 
(Varraso et al. 2002), and hyperpermeability 
of the lung epithelium (Bonetto et al. 2006; 
Carbonnelle et al. 2002, 2008). Increased 
permeability of the lung epithelium has been 
evaluated extensively, and some authors sug-
gest that it may result in increased airway 
inflammation and higher risk of sensitization 
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Background: Swimming in chlorinated pools involves exposure to disinfection by-products 
(DBPs) and has been associated with impaired respiratory health.
oBjectives: We evaluated short-term changes in several respiratory biomarkers to explore mecha-
nisms of potential lung damage related to swimming pool exposure.
Methods: We measured lung function and biomarkers of airway inflammation [fractional exhaled 
nitric oxide (FeNO), eight cytokines, and vascular endothelial growth factor (VEGF) in exhaled breath 
condensate], oxidative stress (8-isoprostane in exhaled breath condensate), and lung permeability 
[surfactant protein D (SP-D) and the Clara cell secretory protein (CC16) in serum] in 48 healthy 
nonsmoking adults before and after they swam for 40 min in a chlorinated indoor swimming pool. 
We measured trihalomethanes in exhaled breath as a marker of individual exposure to DBPs. Energy 
expenditure during swimming, atopy, and CC16 genotype (rs3741240) were also determined.
results: Median serum CC16 levels increased from 6.01 to 6.21 µg/L (average increase, 3.3%; 
paired Wilcoxon test p = 0.03), regardless of atopic status and CC16 genotype. This increase was 
explained both by energy expenditure and different markers of DBP exposure in multivariate mod-
els. FeNO was unchanged overall but tended to decrease among atopics. We found no significant 
changes in lung function, SP-D, 8-isoprostane, eight cytokines, or VEGF.
conclusions: We detected a slight increase in serum CC16, a marker of lung epithelium perme-
ability, in healthy adults after they swam in an indoor chlorinated pool. Exercise and DBP exposure 
explained this association, without involving inflammatory mechanisms. Further research is needed 
to confirm the results, establish the clinical relevance of short-term serum CC16 changes, and evalu-
ate the long-term health impacts.
key words: biomarkers, Clara cell secretory protein, disinfection by-products, exhaled breath 
condensate, fractional exhaled nitric oxide, respiratory health, swimming, swimming pools, 
 trihalomethanes. Environ Health Perspect 118:1538–1544 (2010). doi:10.1289/ehp.1001961 
[Online 12 September 2010]
Respiratory biomarkers after swimming in a pool
Environmental Health Perspectives • volume 118 | number 11 | November 2010 1539
and allergic diseases (Bernard 2007). The role 
of previous atopic status is unclear because 
some studies have found higher asthma risk 
for swimming pool attendance among atop-
ics (Bernard et al. 2006, 2007, 2008), but 
another has not (Font-Ribera et al. 2009). 
Few studies have measured lung function 
and respiratory biomarkers after swimming 
in chlorinated pools (Carbonnelle et al. 2002, 
2008; Moreira et al. 2008; Pedersen et al. 
2009). Lung function and FeNO were consis-
tently unaltered in the studies, but contradic-
tory results were obtained for lung epithelium 
permeability, estimated with serum levels of 
surfactant proteins. Consequently, the evi-
dence remains inconclusive and inconsistent 
for some biomarkers, too.
The aim of this study was to explore short-
term respiratory changes in healthy adults 
after swimming in an indoor chlorinated 
swimming pool by measuring lung function 
and a wide range of biomarkers that may 
reflect different mechanisms of effect, spe-
cifically, airway inflammation (FeNO, eight 
cytokines, and a growth factor in EBC), oxi-
dative stress (8-isoprostane in EBC), and epi-
thelial lung permeability (SP-D and CC16 in 
serum), taking into account both exposure 
to DBPs and physical exercise. Associations 
between swimming and these outcomes may 
provide clues regarding potential mechanisms 
through which swimming-related exposures 
might affect respiratory health.
Materials and Methods
Design. The study has a crossover design 
involving 50 nonsmoking adults who were 
recruited through open advertisements on the 
Internet and at local universities. A screen-
ing questionnaire was used to verify eligi-
bility among subjects (nonsmoking adults, 
18–50 years of age, without respiratory dis-
eases such as ever asthma or having had a cold 
in the preceding 3 weeks). Participants were 
requested to avoid swimming pools during the 
week before the session and to avoid taking a 
shower the day of the swimming experiment. 
The study was approved by the ethics commit-
tee of the research center following the inter-
national regulations, and all volunteers signed 
an informed consent before participation.
A single, indoor, 25-m-long chlorinated 
swimming pool in Barcelona, Spain, was 
used for the study. Every day, one to four 
participants were evaluated between 0900 
and 1400 hours (before lunch) in May, June, 
September, or October 2007. Before and after 
the subjects swam in the chlorinated pool 
for 40 min, a battery of measurements and 
biological samples was collected to evaluate 
respiratory biomarkers according to a strict 
schedule (Figure 1). Biological samples and 
measurements before and after the swim were 
obtained in a room inside the sports center 
where the swimming pool was located but 
separated from the swimming pool area.
Respiratory biomarkers. 8-Isoprostane 
and cytokines. EBC was obtained approxi-
mately 70 min before swimming began 
and 35 min after swimming ended using 
an EcoScreen condenser (Jaeger GmbH, 
Würzburg, Germany) following American 
Thoracic Society/European Respiratory 
Society Task Force recommendations 
(Horvath et al. 2005). Samples were obtained 
through breathing at normal frequency and 
tidal volume until a total expiratory volume of 
180 L was achieved. After collection, the con-
densing device was centrifuged at 4°C, and 
the resultant total EBC volume (~ 4 mL) was 
transferred into Eppendorf tubes and rapidly 
frozen in liquid nitrogen. All samples were 
lyophilized and stored at –80°C before analy-
sis. 8-Isoprostane was analyzed through an 
enzyme-linked immunosorbent assay (ELISA; 
Cayman Chemical, Ann Arbor, MI, USA). 
Using the BD Cytometric Bead Array (CBA; 
BD Biosciences, Erembodegem, Belgium) 
and the BD FACSCalibur Flow Cytometer 
(Becton Dickinson, San Jose, CA, USA), a 
particle-based immunoassay, we determined 
levels of the following eight cytokines and a 
growth factor: RANTES (regulated upon acti-
vation, normal T-cell expressed, and secreted), 
vascular endothelial growth factor (VEGF), 
tumor necrosis factor (TNF), interleukin (IL) 
12p70, IL-4, IL-8, IL-10, interferon-gamma 
(IFN-γ), and IFN-γ–induced protein 10 
(Ip10). Levels were characterized as picograms 
per milliliter of EBC.
CC16 and surfactant pneumoprotein 
D (SP-D). Two 5-mL Vacutainer serum 
tubes were collected from each participant 
by venipuncture before swimming and 
70 min after swimming. Samples were cen-
trifuged at 2,500 rpm for 15 min, and serum 
was subsequently distributed in 1.8-mL ali-
quots and stored at –80°C. CC16 and SP-D 
were analyzed by ELISA using commercial 
kits (Biovendor Laboratorní medicína a.s., 
Modrice, Czech Republic). Intra- and inter-
assay coefficients of variation ranged from 
2.0% to 2.5% in both cases for serum SP-D 
and from 4.0% to 5.0% in both cases for 
serum CC16. The minimum detectable con-
centration in serum was set at 0.2 ng/mL for 
SP-D and 20 pg/mL for CC16 (Biovendor 
Laboratorní medicína a.s.). Levels were 
expressed as micrograms per liter of serum.
FeNO. FeNO was measured 40 min before 
and 80 min after swimming with an electro-
chemical portable device (NIOX-MINO; 
Aerocrine, Solna, Sweden), with a constant 
airflow rate of 50 mL/sec. Duplicate meas-
urement was performed in 50% of the partici-
pants to evaluate reproducibility, resulting in a 
coefficient of variation of 9.7% (SD = 10.6). 
Levels were expressed as parts per billion.
Lung function. Forced expiratory vol-
ume in 1 sec (FEV1) and forced vital capac-
ity (FVC) were measured 30 min before 
and 60 min after participants swam, with an 
EasyOne portable spirometer (ndd Medical 
Technologies, Zürich, Switzerland) follow-
ing standard recommendations (Miller et al. 
2005). FEV1 and FVC were expressed as the 
percentage from the predicted value by age, 
sex, and height (Roca et al. 1986).
Biomarkers of exposure. The four THMs—
chloroform, bromodichloromethane, dibro-
mochloromethane, and bromoform—were 
measured in exhaled breath before swimmers 
entered the swimming pool (80 min before 
swimming) and just after they swam (5 min 
after leaving the pool) (Figure 1), as markers of 
individual exposure to DBPs. Exhaled breath 
samples were collected using a portable system 
for end-exhaled breath sampling, which has 
been described previously (Lourencetti et al. 
2010). Briefly, volunteers were required to 
breathe through the sampling device equipped 
with an adsorption cartridge packed with 
Tenax TA (Supelco, Bellefonte, PA, USA). A 
total volume of 1 L was collected per person. 
The air passed through a stainless-steel cartridge 
(0.5 cm diameter and 9 cm long) containing 
1.8 g Tenax TA (60/80 mesh). Chloroform, 
bromodichloromethane, dibromochloro-
methane, and bromoform were determined 
by an Automatic Thermal Desorption System 
(ATD 400; Perkin-Elmer, Shelton, CT, USA) 
coupled to an Autosystem gas chromatograph 
with electron capture detection (Perkin-Elmer). 
Concentrations were expressed as micrograms 
per cubic meter.
Figure 1. Study design and timing of the sample 
collection and in situ measurements. Urine was 
also collected for genotoxicity analysis (Kogevinas 
et al. 2010).
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E n v i r o n m e n t a l  m e a s u r e m e n t s . 
Environmental measurements were taken to 
characterize the swimming pool and to com-
plement the exposure assessment to DBP. 
Free chlorine, THMs, and mono-, di-, and 
trichloramine were measured in pool water. 
A 1-L composite water sample was collected 
at four different points of the pool for each 
participant while he or she was swimming. A 
single value for free chlorine, monochloram-
ine, dichloramine, and trichloramine was 
obtained for each participant as measured by 
N,N-diethyl-p-phenylenediamine (DPD) pro-
cedure with a portable photometer (DINKO 
Instruments, Inc., Barcelona, Spain). The 
methods for water and air THM analyses 
have been described elsewhere (Lourencetti 
et al. 2010). Briefly, for THM analyses, 5 mg 
sodium thiosulfate was added to a 40-mL 
glass vial with screw cap and polytetrafluoro-
ethylene-lined silicone septa. Water samples 
were stored at 4°C until laboratory analysis 
on the same day. THMs in water were deter-
mined using a SOLATek 72 Multi-Matrix Vial 
Autosampler (Tekmar Dohrmann, Mason, 
OH, USA) coupled to a purge-and-trap con-
centrator (Tekmar 3100; Tekmar, Cincinnati, 
OH, USA), which transfers the sample directly 
to a gas chromatograph coupled to a mass 
spectrometer (Voyager MS; ThermoQuest 
Finnigan, Manchester, UK) and had a coef-
ficients of variation between 0.98% and 5.6%. 
An indoor air sample for THM measurements 
was collected for each participant with a pump 
located 60 cm above the floor and 1.5 m from 
the pool border, at 7 mL/min flow rate for 
20 min through an adsorption cartridge filled 
with Tenax TA. Quality control was assured by 
daily calibration of the pump. The four THMs 
were measured as described for exhaled breath 
samples and were expressed as micrograms per 
cubic meter. 
Additional air samples were collected to 
measure trichloramine in a subset of the days 
(6 days). Air was collected with a constant 
flow sampling pump (flow rate of 1.2 L/min 
for an mean ± SD of 115 ± 32 min), within 
1 m from the water and at a height of 60 cm 
above the floor level. The instrumental analy-
ses were performed at the Institute for Risk 
Assessment Sciences at Utrecht University 
(Utrecht, the Netherlands) following the 
method described by Hery et al. (1995); fur-
ther details are available elsewhere (Jacobs 
et al. 2007). Trichloramine measurements 
were used for comparison with other swim-
ming pools but were not used as personal 
exposure estimates because only 2 of the 6 
trichloramine measurement days coincided 
with the experimental study involving only 
two participants.
O t h e r  i n f o r m a t i o n  c o l l e c t e d . 
Questionnaires were used to collect informa-
tion on personal and family history of atopic 
diseases, exposure to environmental tobacco 
smoke, diet, sociodemographic data, frequency 
and duration of swimming pool attendance 
and other physical activity, and way of com-
muting to the swimming pool facility. Weight 
and height were measured with standard pro-
cedures. Exercise intensity during swimming 
was estimated using the distance swum by each 
participant during the 40 min. Energy expen-
diture (in kilocalories) was estimated using the 
swimming speed and the weight of the partici-
pant, assuming that swimming at 46 m/min 
equals 11 metabolic equivalent tasks (METs; 
kilocalories per kilogram per hour):
kcal = weight (kg) × speed (m/min) 
 × 40 min × 1 hr/60 min  
 × 11 (kcal/kg/hr)/46 (m/min)
(Ainsworth et al. 2000). Atopic status was 
measured with the Phadiatop test (Pharmacia 
& Upjohn, Uppsala, Sweden), a qualitative 
test for serum-specific immunoglobulin E to 
a mixture of common allergens (Vidal et al. 
2005). A single-nucleotide polymorphism 
in the CC16 gene (rs3741240), known to 
modify gene expression, was genotyped using 
Sequenom (CEGEN-Santiago, San Diego, 
Table 1. Physicochemical parameters in water, air, and exhaled breath and exercise intensity performed 
by participants (n = 48).
Measurement Mean ± SD Median Minimum Maximum
Water
Free chlorine (mg/L) 1.17 ± 0.4 1.10 0.5 2.17
Dichloramine (mg/L) 0.43 ± 0.1 0.46 0.16 0.65
Temperature (°C) 27.2 ± 0.4 27.4 26.5 27.7
pH 7.3 ± 0.1 7.3 6.9 7.5
Chloroform (µg/L) 16.1 ± 3.4 16.7 8.5 20.8
Bromodichloromethane (µg/L) 12.3 ± 2.3 11.9 9.3 22.8
Dibromochloromethane (µg/L) 10.9 ± 3.1 10.5 6.5 22.6
Bromoform (µg/L) 6.1 ± 2.4 5.7 3.0 16.2
Total THMs (µg/L) 45.4 ± 7.3 45.5 35.2 75.2
Air
Chloroform (µg/m3) 35.0 ± 12.3 31.4 19.5 61.6
Bromodichloromethane (µg/m3) 14.6 ± 5.0 13.0 7.5 23.4
Dibromochloromethane (µg/m3) 13.2 ± 4.3 12.4 6.0 26.2
Bromoform (µg/m3) 11.2 ± 5.2 8.4 4.4 22.6
Total THMs (µg/m3) 74.1 ± 23.7 68.9 44.0 124.9
Exhaled breath (after swimming)a
Chloroform (µg/m3) 4.5 ± 1.7 4.6 1.1 8.1
Bromodichloromethane (µg/m3) 1.8 ± 0.5 1.6 0.7 3.2
Dibromochloromethane (µg/m3) 1.2 ± 0.5 1.2 0.3 2.8
Bromoform (µg/m3) 0.5 ± 0.2 0.4 0.1 1.3
Total THMs (µg/m3) 7.9 ± 2.8 7.7 2.3 14.0
Exercise intensitya
Distance swam (km) 0.90 ± 0.4 0.95 0.05 1.75
Energy expenditure (kcal) 248.5 ± 120.6 241.9 16.8 603.3
an = 47.
Table 2. Spearman correlation coefficients (r) between the different exposure indicators measured 
(n = 47).
Medium 
 (concentration)
Water (µg/L) Concentration in exhaled breath after swimming (µg/m3)
Energy 
 expenditure 
(kcal)aFree Cl NHCl2 CHCl3 CHCl2Br CHClBr2 CHBr3 TTHMs
Water (µg/L)
Free Cl 0.24 0.34* 0.48* 0.27 0.35* 0.16
NHCl2 –0.28 –0.22 –0.44* –0.44* –0.50* –0.37* –0.26
CHCl3 –0.24 0.17 0.27 –0.03 –0.32 0.01 0.07 –0.04
CHBr3 –0.03 –0.31* –0.40* –0.05 0.25 0.24 –0.17 0.08
TTHMs –0.04 –0.40* 0.06 0.19 0.18 0.48* 0.14 0.04
Air (µg/m3)
CHCl3 0.19 0.04 0.64* 0.40* 0.13 0.29* 0.52* –0.001
CHBr3 0.24 –0.29* 0.22 0.35* 0.29 0.55* 0.30* 0.12
TTHMs 0.38* –0.13 0.55* 0.48* 0.34* 0.43* 0.53* 0.03
Exhaled breath after (µg/m3)
CHCl3 0.83* 0.60* 0.55* 0.94* 0.14
CHCl2Br 0.80* 0.72* 0.94* 0.18
CHClBr2 0.74* 0.79* 0.18
CHBr3 0.70* 0.32*
TTHMs 0.19
Abbreviations: CHBr3, bromoform; CHClBr2, dibromochloromethane; CHCl2Br, bromodichloromethane; CHCl3, chloroform; 
NHCl2, dichloramine; TTHMs, total THMs. 
aKilocalories expended during the 40 min. *p < 0.05.
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CA, USA). DNA was extracted from periph-
eral blood samples.
Statistical analysis. The distribution of 
each biomarker was evaluated with a test for 
normality evaluating skewness and kurtosis. 
Mean or median values were reported accord-
ingly to describe central tendencies. We 
calculated the individual change in the con-
centration of each biomarker after swimming 
in the pool (concentration after – before). 
Samples with cytokines under the detec-
tion limit before (30.1%) or after (27.1%) 
swimming were imputed half the detection 
limit. Those with undetectable levels before 
and after swimming were excluded from the 
statistical analysis. A nonparametric test was 
used to evaluate whether there was a sig-
nificant change in the concentration of each 
biomarker. Linear regression models were 
fitted to calculate the association between 
changes in the concentration of each respi-
ratory biomarker and the personal markers 
of DBP exposure and exercise intensity. The 
β-coefficient of a change in a unit in the con-
centration of each respiratory marker was 
calculated for an increase from the 25th per-
centile to the 75th percentile in the exposure 
parameters. All covariates were tested in each 
model, and only those that were statistically 
significant were retained in the multivariate 
models. The p-value threshold for statistical 
significance was set up at < 0.05. Interactions 
were tested by introducing the product of 
the variables in the regression model. All the 
statistical analyses were performed with the 
statistical package STATA 8.2 (StataCorp., 
College Station, TX, USA).
Results
We recruited 50 subjects for the study. We 
excluded two subjects with history of asthma 
for the present analysis, resulting in a sam-
ple of 48 subjects. Most participants were 
women (65%) and were highly educated 
(92% with university studies), with an aver-
age age (± SD) of 30 ± 6.1 years, and 30% 
were positive to the Phadiatop test. Twenty 
percent were regular swimmers (at least 
once per month), and 54% practiced sport 
at least once a week. Regarding the CC16 
genotype (A38G), frequencies were 39%, 
12%, and 49% for AG, AA, and GG, respec-
tively. The genotyping frequency was 91%, 
and it was in Hardy–Weinberg equilibrium 
(p = 0.365). Minor allele frequencies were 
similar to those described in the International 
HapMap Project for European individuals 
(International HapMap Consortium 2003). 
The mean (± SD) speed during swimming 
was 22.5 ± 9.7 m/min, and the mean energy 
expenditure was 248.5 ± 120.6 kcal. We had 
one missing value for energy expenditure, one 
for THM in exhaled breath, one for FeNO, 
and three for 8-isoprostane in EBC.
Average free chlorine level in the pool 
water was 1.17 ± 0.4 mg/L. Average total 
THM concentration in water was 45.4 ± 
7.3 µg/L (Table 1). The mean (± SD) level 
of THM in exhaled breath before swimming 
was 1.19 ± 0.40 µg/m3 for total THMs, 0.72 
± 0.28 µg/m3 for chloroform, 0.25 ± 0.09 
µg/m3 for bromodichloromethane, 0.13 ± 
0.06 µg/m3 for dibromochloromethane, and 
0.10 ± 0.07 µg/m3 for bromoform. After 
swimming, THMs in exhaled breath increased 
on average about seven times. The increase 
was similar by age group, sex, or body mass 
index (data not shown). Chloroform levels in 
exhaled breath were significantly correlated 
with levels in the swimming pool’s air, but not 
with levels in water (Table 2). Dichloramine 
in water was inversely and significantly cor-
related with brominated THMs but not with 
chloroform in water, air, and exhaled breath. 
Free chlorine in water was not significantly 
correlated to total THMs in water but was 
significantly correlated to total THMs in air 
and exhaled breath. The energy expenditure 
correlated significantly only with bromoform 
concentration in exhaled breath after swim-
ming. Trichloramine in water was undetect-
able, and monochloramine correlated with the 
same DBPs as dichloramine, so we show only 
dichloramine in the tables.
The concentration of CC16 in serum 
was increased significantly after swimming, 
with an overall median increase of 0.47 µg/L 
(3.3% increase) (Table 3). We detected no 
significant changes in percent predicted 
Table 3. Level of respiratory markers before and after swimming: linear regression coefficients of the change after swimming for the exposure parameters.
Percent predicted
Parameter FEV1 FVC FEV1/ FVC FeNO (ppb) 8-Isoprostane (pg/mL) SP-D (µg/L) CC16 (µg/L)
n 48 48 48 47 45 48 48
Median (IQR)
Before 97.3 
(90.1 to 103.6)
98.1 
(90.0 to 105.4)
0.83 
(0.8 to 0.9)
13 
(10.5 to 18.5)
1.6 
(1.0 to 2.0)
54.4 
(39.3 to 68.0)
6.01 
(3.9 to 7.7)
After 96.3 
(90.4 to 105.1)
95.9 
(90.7 to 104.2)
0.83 
(0.8 to 0.9)
12.5 
(10 to 17.5)
1.3 
(0.6 to 2.5)
55.1 
(45.4 to 85.0)
6.21 
(4.6 to 8.4)
Change –0.6 
(–2.5 to 2.4)
–2.0 
(–5.1 to 3.9)
0.0 
(–0.02 to 0.04)
0.0 
(–2 to 2)
–0.03 
(–0.8 to 1.1)
1.0 
(–3.7 to 6.6)
0.47 
(–0.3 to 1.1)
p-Value (change ≠ 0)a 0.83 0.46 0.24 1.00 0.91 0.44 0.03
Change in respiratory markers for an increase from 25th to 75th percentile in exposure parameters (95% confidence interval)b
Free chlorine to water (mg/L) 0.54 
(–0.90 to 1.99)
–2.44 
(–5.77 to 0.88)
0.02 
(0.00–0.04)*
–1.22 
(–2.51 to 0.06)
0.61 
(–0.17 to 1.39)
0.58 
(–6.26 to 7.42)
1.02 
(0.30–1.74)**
NHCl2 to water (µg/L) –0.50 
(–1.59 to 0.57)
0.12 
(–2.42 to 2.67)
–0.01 
(–0.02 to 0.01)
0.92 
(–0.03 to 1.91)
–0.10 
(–0.71 to 0.51)
2.93 
(–2.10 to 7.97)
-0.84 
(–1.38 to –0.33)**
CHCl3 to exhaled breath (µg/m3) 0.48 
(–0.78 to 1.74)
0.73 
(–2.25 to 3.72)
0.00 
(–0.02 to 0.02)
0.14 
(–1.07 to 1.35)
0.59 
(–0.17 to 1.32)
0.34 
(–5.69 to 6.37)
0.24 
(–0.44 to 0.92)
CHCl2Br to exhaled breath (µg/m3) 0.14 
(–0.77 to 1.06)
–0.43 
(–2.60 to 1.73)
0.00 
(–0.01 to 0.02)
0.22 
(–0.66 to 1.10)
0.43 
(–0.13 to 0.99)
0.87 
(–3.50 to 5.25)
0.55 
(0.08 to 1.02)*
CHClBr2 to exhaled breath (µg/m3) –0.05 
(–1.79 to 1.69)
–1.07 
(–5.18 to 3.03)
0.01 
(–0.02 to 0.03)
0.22 
(–1.43 to 1.88)
0.71 
(–0.29 to 1.70)
1.06 
(–7.22 to 9.35)
1.92 
(1.19 to 2.67)**
CHBr3 to exhaled breath (µg/m3) 0.35 
(–0.97 to 1.65)
–0.05 
(–3.16 to 3.06)
0.00 
(–0.02 to 0.02)
–0.07 
(–1.53 to 1.38)
0.32 
(–0.41 to 1.05)
3.13 
(–3.09 to 9.30)
1.21 
(0.59 to 1.82)**
TTHMs to exhaled breath (µg/m3) 0.31 
(–0.79 to 1.44)
0.17 
(–2.49.2.81)
0.00 
(–0.02 to 0.02)
0.17 
(–0.93 to 1.24)
0.54 
(–0.12 to 1.20)
0.76 
(–4.57 to 6.10)
0.59 
(0.02 to 1.18)*
Energy expenditure (kcal) –0.65 
(–2.03 to 0.73)
–2.97 
(–6.10 to 0.17)
0.02 
(–0.00 to 0.04)
0.20 
(–1.14 to 1.54)
0.98 
(0.22 to 1.74)*
0.85 
(–5.73 to 7.41)
1.04 
(0.37 to 1.73)**
Abbreviations: CHBr3, bromoform; CHClBr2, dibromochloromethane; CHCl2Br, bromodichloromethane; CHCl3, chloroform; NHCl2, dichloramine; TTHMs, total THMs. Percent predicted 
refers to percentage of that predicted by age to sex to and height. SP-D and CC16 were measured in serum. 8-Isoprostane was measured in EBC. 
aWilcoxon test. bβ-Coefficients from linear regression models represent a change in the biomarker level for an increase from 25th to 75th percentile of the exposure parameter. FeNO 
models are adjusted for rhinitis; 8-isoprostane models are adjusted for usual swimming pool attendance. The other models are crude.*p < 0.05. **p < 0.01.
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FEV1, percent predicted FVC, FEV1/FVC, 
FeNO, serum SP-D, 8-isoprostane (Table 3), 
or cytokines in EBC (Table 4). The increase 
in serum CC16 concentration was signifi-
cantly correlated with different indicators 
of DBP exposure (negatively with dichlora-
mine in water and positively with free chlo-
rine in water and bromo dichloromethane, 
dibromochloromethane, and bromoform in 
exhaled breath) and with energy expenditure 
(Table 3, Figure 2). In multivariate models, 
both energy expenditure and markers of DBP 
exposure remained significantly associated 
with the increase in CC16 after mutual adjust-
ment (Table 5). An interquartile range (IQR) 
increase in energy expenditure was associated 
with a significant increase in 8-isoprostane 
in EBC after swimming. We found an inter-
action with the change in 8-isoprostane and 
swimming regularly (p-value = 0.04). 8-Iso-
prostane decreased among those who swam 
regularly (median change, –1.0 pg/mL; 
SD = 1.2; p-value = 0.04), whereas it tended to 
increase among those who did not swim regu-
larly (0.62 pg/mL; SD = 2.1; p-value = 0.09).
When we calculated the change in the 
biomarker concentration as a relative measure 
[(levels after – before)/levels before], we found 
the same patterns. Bivariate analyses showed 
that the changes in the levels of these respira-
tory biomarkers did not differ by sex, age, 
body mass index, or the time spent in active 
commuting (walking or cycling) to the swim-
ming pool facility. Atopic participants had 
higher baseline FeNO concentrations than 
did nonatopic participants, and they tended 
to have a decrease in FeNO after swimming, 
whereas nonatopic subjects remained stable 
(Figure 3). The increase in CC16 concentra-
tion in serum was not modified significantly 
by atopic status. Furthermore, CC16 change 
was not different among CC16 genotypes, 
modeled as dichotomous (GG vs. AA/AG; 
p-value = 0.507) (data not shown).
Discussion
We detected a slight but significant increase 
in lung epithelial permeability, as estimated 
by serum CC16, in healthy adult volunteers 
after swimming in a chlorinated pool. Energy 
expenditure during swimming and change 
in THM concentrations in exhaled breath 
after swimming (indicating higher DBP expo-
sures) were significant predictors of increases 
in serum CC16, suggesting that these expo-
sures may have contributed to an increase in 
lung permeability. We observed no significant 
changes in lung function tests or markers of 
inflammation or oxidative stress in adults after 
swimming in a chlorinated pool.
The lack of an association between swim-
ming and lung function and FeNO was 
consistent with previous studies with a com-
parable design (Carbonnelle et al. 2002, 2008; 
Moreira et al. 2008; Pedersen et al. 2009). 
However, evidence for serum CC16 is less 
consistent. Serum CC16 did not vary signifi-
cantly in 11 young adults (Carbonnelle et al. 
2008) and in 16 children (Carbonnelle et al. 
2002), whereas it decreased (29% decrease) 
among 13 adults after swimming in a chlori-
nated pool, with a concentration of trichloram-
ine in air between 160 and 280 µg/m3 in 
one study (Carbonnelle et al. 2008) and of 
490 µg/m3 in the other (Carbonnelle et al. 
2002). Carbonnelle et al. (2002) detected an 
increase in serum CC16 levels among 14 elite 
swimmers after they swam in a chlorinated 
pool (44% increase) and a nonchlorinated 
pool (52% increase), suggesting that the 
hyperpermeability of the lung epithelium after 
swimming could be caused by physical activ-
ity (Nanson et al. 2001). We showed in the 
present study that the both exercise intensity 
during swimming and markers of DBP expo-
sure were associated with the increase in serum 
CC16 after mutual adjustment, supporting 
the hypothesis of independent effects of exer-
cise and chemical exposure on the permeabil-
ity of the lung epithelium.
The unchanged concentration of 8-iso-
prostane after swimming suggests the lack 
of association with oxidative stress in the 
airways. However, 8-isoprostane tended to 
increase with energy expenditure, in accor-
dance with a previous study showing that oxi-
dative stress increases after physical exercise 
in healthy subjects (Moller et al. 1996). We 
detected no changes in the eight cytokines 
and one growth factor measured in EBC, in 
Table 4. Concentration of eight cytokines and VEGF (pg/mL) in EBC before and after swimming.
Median (IQR) RANTES Ip10 VEGF TNF IL-12p70 IL-10 IL-8 IFN-γ IL-4
na 31 36 44 39 39 43 40 32 38
Before 0.85 
(0.0 to 2.0)
1.18 
(0.1 to 2.5)
3.63 
(1.5 to 8.2)
0.89 
(0.4 to 1.7)
0.66 
(0.0 to 1.0)
0.89 
(0.2 to 1.5)
1.24 
(0.7 to 2.2)
1.29 
(0.0 to 1.8)
0.70 
(0.3 to 2.0)
After 1.17 
(0.4, 1.6)
1.33 
(0.0 to 2.2)
4.41 
(2.3 to 7.1)
0.71 
(0.4 to 1.6)
0.31 
(0.0 to 0.7)
0.84 
(0.0 to 1.5)
1.42 
(0.4 to 2.2)
1.25 
(0.0 to 2.4)
0.72 
(0.3 to 1.1) 
Change –0.20 
(–0.8, 1.1)
–0.08 
(–1.3 to 1.3)
0.11 
(–3.4 to 4.0)
–0.16 
(–0.7 to 0.7)
0.00 
(–0.6 to 0.0)
–0.15 
(–0.6 to 0.7)
0.00 
(–0.7 to 0.4)
–0.02 
(–1.5 to 1.5)
–0.07 
(–1.2 to 0.7)
p-Value (change ≠ 0)b 0.631 0.683 0.879 0.477 0.107 0.740 0.898 0.903 0.658
aSamples with undetectable levels were imputed half of the detection limit; participants with undetectable levels before and after swimming were excluded. bWilcoxon test.
Figure 2. Correlation between the change in serum CC16 concentration and dibromochloromethane 
(CHClBr2) in exhaled breath, energy expenditure during swimming, free chlorine in water, and dichlor-
amine (NHCl2) in water.
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accordance with a previous study that did not 
find changes in other markers of inflammation 
in 21 adolescents after they swam in a chlori-
nated pool (Pedersen et al. 2009). Although 
the concentrations of cytokines in EBC of our 
healthy study population were relatively low 
(~ 1 pg/mL), they were detectable in most 
samples (~ 80%). However, partly because 
of the lack of appropriate reference values, 
the validity of using these proteins in EBC 
as markers of acute inflammation in healthy 
subjects needs to be determined.
The present study has a larger sample size 
than previous studies with a similar design 
[n = 48, vs. 30 (Moreira et al. 2008), 29 
(Carbonnelle et al. 2002), 21 (Pedersen et al. 
2009), and 11 (Carbonnelle et al. 2008)]. 
However, statistical power could still be lim-
ited for detecting minor changes in some 
biomarkers with statistically significance. We 
selected the timing of sample collection to 
account for the specific expression dynam-
ics of the different biomarkers and highly 
controlled this timing during field work. 
However, available data on expression dynam-
ics of some biomarkers were limited or incon-
sistent. For example, an increase in FeNO 
has been observed right after swimming 
(Carbonnelle et al. 2002) and also 6 hr after 
mold exposure (Stark et al. 2005). Therefore, 
undetected changes in some biomarkers due 
to inappropriate sample timing cannot be 
ruled out. Although THMs are not irritants 
and are not likely the putative agents for the 
respiratory effects associated to the swimming 
pool environment, we used their occurrence 
in exhaled breath as a surrogate for DBP dose 
because THMs are the most prevalent DBPs 
in swimming pools and are easy to measure 
in exhaled breath. The observed dichloram-
ine concentrations (0.43 mg/L; Table 1) in 
water were low compared with other swim-
ming pools using chlorine for disinfection 
(Weaver et al. 2009). Furthermore, we used 
the same DPD method for all participants; 
therefore, the influence of the biases should be 
minimal. The season when we conducted the 
study (spring–summer) probably represented 
lower levels of DBP exposures than would the 
rest of the year because the facility was highly 
ventilated with doors and windows opened. 
Trichloramine in the air ranged from 0.17 to 
0.43 mg/m3 (mean, 0.29 mg/m3), which is 
below the World Health Organization (2006) 
recommendations of 0.5 mg/m3 but compara-
ble to the study by Carbonnelle et al. (2008).
The measurement of a battery of respi-
ratory biomarkers allowed us to explore 
short-term respiratory changes that may 
reflect different mechanisms of respiratory 
effect in relation to swimming pool expo-
sure. However, there is limited knowledge 
of the clinical significance to interpret the 
health impacts of the biomarkers measured. 
The present study replicates with a higher 
sample size the methods of previous studies 
and provides new evidence on biomarkers not 
measured previously, including markers in 
EBC. It suggests for the first time that atopic 
status and CC16 genotype do not modify the 
effect of swimming in a pool on the perme-
ability of the lung epithelium. Furthermore, 
we attempted to disentangle the effects of 
chemical exposure and exercise by measuring 
individual exposure to DBPs and energy 
expenditure during swimming.
The increase in serum CC16 after swim-
ming in a well-maintained and highly ventilated 
indoor swimming pool confirms the high sensi-
tivity of this assay to detect subtle changes in 
the concentration of this biomarker after envi-
ronmental exposures. The fact that we detected 
no differences in serum CC16 levels by CC16 
genotype further supports the hypothesis that 
Table 5. Multiple linear regressions between serum CC16 concentration (µg/L) in relation to a unit 
increase in indicators of DBP exposure and energy expenditure.
Model Variables β (95% CI) p-Value R 2 n
1 CHClBr2, exhaled breath (µg/m3) 1.68 (0.93 to 2.43) < 0.001 0.45 46
Energy expenditure (kcal) 0.69 (0.09 to 1.28) 0.024
2 CHClBr2, exhaled breath (µg/m3) 1.49 (0.65 to 2.33) 0.001 0.46 46
Energy expenditure (kcal) 0.68 (0.08 to 1.27) 0.027
Free chlorine (mg/L) 0.33 (–0.35 to 1.01) 0.336
3 CHCl2Br, exhaled breath (µg/m3) 0.45 (0.01 to 0.89) 0.047 0.26 46
Energy expenditure (kcal) 0.97 (0.30 to 1.64) 0.005
4 CHCl2Br, exhaled breath (µg/m3) 0.35 (–0.09 to 0.78) 0.117 0.34 46
Energy expenditure (kcal) 0.87 (0.22 to 1.51) 0.010
Free chlorine (mg/L) 0.77 (0.08 to 1.46) 0.030
5 CHBr3, exhaled breath (µg/m3) 0.98 (0.31 to 1.65) 0.005 0.33 46
Energy expenditure (kcal) 0.66 (–0.03 to 1.35) 0.060
6 CHBr3, exhaled breath (µg/m3) 0.82 (0.16 to 1.48) 0.016 0.39 46
Energy expenditure (kcal) 0.61 (–0.05 to 1.28) 0.070
Free chlorine (mg/L) 0.69 (0.03 to 1.36) 0.042
7 TTHMs, exhaled breath (µg/m3) 0.46 (–0.10 to 1.02) 0.105 0.24 46
Energy expenditure (kcal) 0.97 (0.29 to 1.65) 0.006
8 TTHMs, exhaled breath (µg/m3) 0.30 (–0.25 to 0.86) 0.274 0.32 46
Energy expenditure (kcal) 0.88 (0.22 to 1.53) 0.010
Free chlorine (mg/L) 0.79 (0.08 to 1.49) 0.030
9 Free chlorine (mg/L) 0.85 (0.16 to 1.54) 0.017 0.28 47
Energy expenditure (kcal) 0.90 (0.25 to 1.56) 0.008
Abbreviations: CHClBr2, dibromochloromethane; CHCl2Br, bromodichloromethane; CHBr3, bromoform; CI, confidence 
interval; TTHMs, total THMs. No other variables were included in the models.
Figure 3. Concentration of FeNO and serum CC16 before (B) and after (A) swimming, stratified by atopic 
status (median and IQR). The Phadiatop test was used to define atopic status. p-Value from a Mann–
Whitney test between atopics and nonatopics: 0.022 for FeNO and 0.560 for CC16.
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the association is attributable to an increased 
permeability of the lung epithelium rather than 
an increase in CC16 synthesis, which may dif-
fer by genotypes (Laing et al. 2000). The higher 
molecular weight of SP-D (130 kDa) (Kishore 
et al. 2006) compared with CC16 (16 kDa) 
(Broeckaert et al. 2000) probably explains the 
lack of increase in serum concentration of this 
protein after swimming because its higher 
molecular weight would not permit the passive 
diffusion of the molecule through the epithe-
lium barrier. Previous studies that measured 
other surfactant proteins (SP-A and SP-B) in 
serum in similar settings found inconsistent 
results (Carbonnelle et al. 2002, 2008).
We assessed the role of atopy as an effect 
modifier because some epidemiologic studies 
have reported an increased asthma risk for 
swimming pool attendance among atopic chil-
dren (Bernard et al. 2006, 2007, 2008, 2009). 
Baseline serum CC16 levels and the change 
after swimming were similar among atopics 
and nonatopics. Atopic status did not modify 
the effect of swimming pool exposure on the 
markers studied or on pulmonary function, 
in agreement with a previous study (Bonetto 
et al. 2006). However, atopic participants 
had higher baseline FeNO levels, and atopy 
modified the effect of swimming (p = 0.02). 
FeNO remained unchanged among nonatop-
ics, whereas it tended to decrease among atop-
ics. Moreira et al. (2008) found no changes 
on FeNO that did not vary by atopic status 
or asthma in 30 competitive swimmers after a 
training session.
Among the battery of respiratory bio-
markers evaluated, only serum CC16 levels 
changed significantly after swimming. Given 
the moderate increase detected (3.3%), the 
high variability in CC16 levels in healthy sub-
jects (Broeckaert et al. 2000), and the lack of 
reference values of CC16, the clinical relevance 
of this short-term effect is unclear (Carbonnelle 
et al. 2008), and further studies are neces-
sary to establish the health impacts of short-
term serum CC16 changes (Broeckaert et al. 
2000; Lakind et al. 2007). Further, previous 
studies have shown that this acute increase in 
serum CC16 is transient and that serum CC16 
returns to baseline levels a few hours after expo-
sure ceases (Carbonnelle et al. 2002, 2008). We 
interpret the increase in lung epithelial perme-
ability after swimming as an acute physiologi-
cal reaction of the lung caused by exercise and 
exposure to some DBPs. Long-term effects can-
not be extrapolated from these results until the 
clinical and physiological relevance of CC16 
short-term change is understood further.
Our exposure-assessment data have been 
used in a companion paper in this issue by 
Kogevinas et al. (2010), who showed that 
swimming produced genotoxic effects that 
were associated with the concentrations of bro-
minated THMs, but not chloroform, in the 
swimmers’ exhaled breath. This finding was 
supported by another companion paper in this 
issue by Richardson et al. (2010), who identi-
fied > 100 DBPs in the pool water and showed 
that the water was mutagenic. 
In summary, we detected a slight increase 
in serum CC16, which is a marker of lung 
epithelium permeability, in healthy adults after 
40 min of swimming in an indoor chlorinated 
pool. Exercise and DBP exposure explained 
this association, without involving further 
inflammatory mechanisms. Further research is 
needed to confirm the results, disentangle the 
effects of exercise and DBP exposure, estab-
lish the clinical relevance of short-term serum 
CC16 changes, and evaluate the long-term 
respiratory health impacts of swimming.
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